Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
Donovan J, Bang ND, Imran D, Nghia HDT, Burhan E, Huong DTT, Hiep NTT, Ngoc LHB, Thanh DV, Thanh NT, Wardhani ALS, Maharani K, Gasmara CP, Hanh NHH, Oanh PKN, Estiasari R, Thu DDA, Kusumaningrum A, Dung LT, Giang DC, Ha DTM, Lan NH, Chau NVV, Nguyet NTM, Geskus RB, Thuong NTT, Kestelyn E, Hamers RL, Phu NH, Thwaites GE; ACT HIV Investigators.
Donovan J, et al.
N Engl J Med. 2023 Oct 12;389(15):1357-1367. doi: 10.1056/NEJMoa2216218.
N Engl J Med. 2023.
PMID: 37819954
Free PMC article.
Clinical Trial.
Participants were randomly assigned to receive a 6-to-8-week tapering course of either dexamethasone or placebo in addition to 12 months of antituberculosis chemotherapy. ...
Participants were randomly assigned to receive a 6-to-8-week tapering course of either dexamethasone or placebo in addition to 12 mon …